Nektar prices equity offering at $13.50; shares down 3% premarket

• Nektar Therapeutics (NASDAQ:NKTR) eases 3% premarket on average volume in response to the pricing of its public offering of 13M shares of common stock at $13.50. Underwriters over-allotment is an additional 1.95M shares. Net proceeds will fund R&D, working capital and general corporate purposes.
• Yesterday's close was $14.08.